Hematopoietic cell transplantation is a curative treatment for a variety of hematologic
diseases. Advances in transplantation technology have reduced early transplant-related …

Hematopoietic stem cell transplant (HCT) recipients have a substantial risk of developing
secondary solid cancers, particularly beyond 5 years after HCT and without reaching a …

Chronic GvHD (cGvHD) of the genital tract is an underreported and infrequently recognized
complication of allogeneic hematopoietic cell transplantation in both male and female long …

The increasing indications for allogeneic stem-cell transplant in patients with hematologic
malignancies and non-malignant diseases combined with improved clinical outcomes have …

Immune reconstitution after hematopoietic stem cell transplantation (HCT) beyond 1 year is
not completely understood. Many transplant recipients who are free of graft-versus-host …

Infections significantly impact outcomes for solid organ and hematopoietic stem cell
transplantation in children. Vaccine‐preventable diseases contribute to morbidity and …

An increasing proportion of cancer patients benefit from new treatment strategies. However,
infection remains a main cause of morbidity and mortality, either due to the underlying …

Optimum care of female transplant recipients requires gynecologic care at several stages
through the allogeneic hematopoietic stem cell transplantation (HCT) process. Sex-based …

The updated second edition of Cutaneous Manifestations of Infection in the
Immunocompromised Host is an invaluable reference for physicians and ancillary medical …

Human papilloma virus (HPV) is a known cause of cervical cancer, squamous cell
carcinoma and laryngeal cancer. Although treatments exist for HPV-associated …